KAM

Krensavage Asset Management Portfolio holdings

AUM $235M
1-Year Est. Return 42.5%
This Quarter Est. Return
1 Year Est. Return
+42.5%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$189M
AUM Growth
+$8.05M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
16
New
Increased
Reduced
Closed

Top Buys

1
+$6.8M
2
+$6.11M
3
+$2.1M
4
VNDA icon
Vanda Pharmaceuticals
VNDA
+$1.28M
5
SUPN icon
Supernus Pharmaceuticals
SUPN
+$1.27M

Top Sells

1
+$17M
2
+$9.24M
3
+$1.51M
4
MURA
Mural Oncology
MURA
+$89K
5
ENTA icon
Enanta Pharmaceuticals
ENTA
+$16.2K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UTHR icon
1
United Therapeutics
UTHR
$21.3B
$29.1M 15.38%
101,146
+2,918
CAH icon
2
Cardinal Health
CAH
$47.1B
$22.5M 11.89%
133,745
-55,000
EXEL icon
3
Exelixis
EXEL
$11B
$21.8M 11.51%
493,526
-385,007
JAZZ icon
4
Jazz Pharmaceuticals
JAZZ
$10.2B
$17.5M 9.26%
164,816
+64,113
ENTA icon
5
Enanta Pharmaceuticals
ENTA
$425M
$16M 8.46%
2,114,444
-2,142
SUPN icon
6
Supernus Pharmaceuticals
SUPN
$2.7B
$14.9M 7.88%
472,376
+40,390
INDV icon
7
Indivior
INDV
$4.45B
$14.4M 7.6%
974,474
+9,106
GSK icon
8
GSK
GSK
$98.5B
$10.4M 5.52%
271,729
-271
AVDL
9
Avadel Pharmaceuticals
AVDL
$2.1B
$8.49M 4.49%
958,877
+8,877
BNTX icon
10
BioNTech
BNTX
$22.8B
$7.81M 4.14%
73,382
-14,181
SNY icon
11
Sanofi
SNY
$118B
$7.2M 3.81%
148,946
-150
JNJ icon
12
Johnson & Johnson
JNJ
$510B
$6.11M 3.23%
+40,000
ALKS icon
13
Alkermes
ALKS
$4.71B
$5.95M 3.15%
207,822
VNDA icon
14
Vanda Pharmaceuticals
VNDA
$368M
$4.84M 2.56%
1,024,883
+270,502
REGN icon
15
Regeneron Pharmaceuticals
REGN
$77.9B
$2.1M 1.11%
+4,000
MURA
16
DELISTED
Mural Oncology
MURA
– –
-70,263